PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Independent Bo

18 Aug 2008 07:00

RNS Number : 4921B
Phorm Inc
18 August 2008
 



Phorm, Inc. ("Phorm" or the "Company") 

Phorm Elects Steven J. Heyer as Independent Board Chairman 

Phorm (AIM: PHRM and PHRX), the advertising technology company, today announces the election of Non-Executive Director, Steven J. Heyer, as Board Chairman. Kent Ertugrul will continue to lead the Company as Chief Executive Officer, driving the implementation of Phorm's business strategy and technology. The appointment takes effect immediately and will strengthen Phorm's corporate governance while providing a solid leadership platform for future growth as the Company moves to the next stage of its development.

Mr. Heyer, aged 56, joined the Phorm Board in October 2007 and brings with him over three decades of global management experience, strong marketing skills and a deep knowledge of the development of brands. He is the Co-Chairman and CEO of Fathom Studios, a CG animation company, and the former CEO of Starwood Hotels & Resorts Worldwide; President and COO of Coca-Cola Company; President and COO of Turner Broadcasting System, Inc.; and President and COO of Young and Rubicam, Inc. Mr. Heyer is also a member of the Board of Directors of Lazard Group, Omnicare Inc., Vitrue Inc., a social networking company, NCAA, and Special Olympics.

Kent Ertugrul, Chief Executive Officer of Phorm, Inc., said: "Splitting the role of Chairman and Chief Executive will enable me to focus more of my time and efforts on driving our vision. I am very pleased to be working even more closely with Steve. Steve's broad business experience, commercial acumen and deep knowledge of the media, advertising and ISP industries will continue to prove invaluable to Phorm going forward. Our collaboration has proved very effective in implementing our vision for Phorm. We have the right strategy in place and great momentum and I am confident this change will further strengthen our business."

Steven Heyer commented: "Kent and the management team have made very significant progress in executing the Company's strategy, developing Phorm's proprietary technology platform and building strong relationships with ISPs, advertisers and publishers. Our strategy is sound and, as Chairman, I look forward to working even more closely with Kent, our team and our partners. We are all very enthusiastic about Phorm's future growth potential. The Board is committed to positioning the Company for success and delivering value to our shareholders."

For Phorm Enquiries:

Lynne Millar (Chief Financial Officer) +44 20 7638 9571

Citigate Dewe Rogerson +44 20 7638 9571

Simon Rigby

Justin Griffiths

Canaccord Adams Limited +44 20 7050 6500

(Nominated Advisor)

Mark Williams

Andrew Chubb

About Phorm: 

Phorm is an innovative technology company specialising in delivering behaviourally and contextually targeted advertising while preserving users' personal privacy and security. 

Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Ad Networks and Advertisers.

Phorm is a Delaware corporation, with offices in New York, London and Moscow. The Company was admitted to the AIM market of the London Stock Exchange in 2004 and has over 100 employees.

For more information, please visit: www.phorm.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPRMJTMMMBTLP
Date   Source Headline
26th Mar 20145:00 pmRNSIntention to raise £10 million
10th Mar 20147:01 amRNSMemorandum of Understanding with China Telecom
27th Jan 20147:00 amRNSCommercial Launch in China
20th Jan 20147:00 amRNSChange of Adviser
17th Jan 20147:00 amRNSAIM Rule 17 Disclosure Schedule Two (g) Update
6th Jan 20147:00 amRNSExercise of Employee Warrants for Shares
19th Nov 20137:00 amRNSOperational Update for Phorm China
19th Nov 20137:00 amRNSEquity Placing to raise £10 million
13th Nov 20137:12 amRNSStmnt re Share Price Movement
24th Oct 201311:16 amRNSOperations Update
3rd Oct 20137:00 amRNSOperational Launch in China
30th Sep 20137:00 amRNSInterim Results
27th Sep 20137:00 amRNSOperations Update
28th Aug 201312:43 pmRNSAGM Statement
7th Aug 201310:52 amRNSStmnt re Share Price Movement
6th Aug 20137:00 amRNSAGM Statement
26th Jul 20137:00 amRNSTR1: Notification of major interest in shares
26th Jul 20137:00 amRNSTR1: Notification of major interest in shares
17th Jul 20139:20 amRNSIssue of Equity
28th Jun 20137:20 amRNSAnnual Report and Financial Statements
28th Jun 20137:20 amRNSTurkish Operations Update
29th May 20137:00 amRNSFinancing Update
8th May 20138:34 amRNSHolding(s) in Company
23rd Apr 201310:18 amRNSPlacing to raise £7.15 million
21st Mar 20133:20 pmRNSStatement re Share Price Movement
20th Mar 20137:00 amRNSFinancing Update
24th Jan 20137:00 amRNSChinese and Turkish Operations Update
4th Jan 20137:00 amRNSIssue of Shares
18th Dec 20127:00 amRNSIssue of Shares
17th Dec 20127:00 amRNSTurkish Operational Update
13th Dec 20127:00 amRNSTR1: Notification of major interest in shares
21st Nov 201212:33 pmRNSResult of EGM & Admission to trading
6th Nov 201211:50 amRNS£6m Placing, Contract Signature & Turkey Update
16th Oct 20127:00 amRNSCommercial Progress Update
28th Sep 20127:00 amRNSInterim Results
20th Sep 20127:00 amRNSUpdate on Turkey and Phorm China Equity Fundraise
11th Sep 20127:00 amRNSAdmission to Trading
10th Sep 20123:33 pmRNSSch 1 Update - Phorm Corporation Limited
7th Sep 20122:58 pmRNSResults of EGM - Correction
7th Sep 201212:29 pmRNSResults of EGM
5th Sep 20124:15 pmRNSNotification of Major Interests in Shares
31st Aug 20123:49 pmRNSUpdated Appendix to Schedule 1
13th Aug 20129:06 amRNSSchedule 1 - Phorm Corporation Limited
13th Aug 20127:00 amRNSPhorm Re-Domicile of Holding Company from Delaware
2nd Aug 20127:00 amRNSPlacing
9th Jul 20127:00 amRNSCommencement of Commercial Activities with TTNET
3rd Jul 201210:14 amRNSTransfer of Shares
29th Jun 20127:00 amRNSAnnual Financial Report
19th Jun 20126:01 pmRNSCorrection: AGM Result
19th Jun 201211:29 amRNSAGM Result

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.